References
- Johnson MPT, Leary JM. Management of dental patients with bleeding disorders: review and update. Oral Surg Oral Med Oral Pathol 1988: 66(3): 297–303
- Salzman EW. Hemostatic problems in surgical patients. In: Colman RW, Hirsh J, Mardr VJ, et al, eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott, 1987: 921
- Czapek EE, Deykin D, Salzman E, et al. Intermediate syndrome of platelet dysfunction. Blood 1978: 52(1): 103–13
- Stuart MJ, Miller ML, Davey FR et al. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 1979: 43(4): 649–59
- Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972: 287(4): 155–9
- Olson RE. Vitamin K. In: Colman et al, eds,2 p 855
- Hull R, Hirsh J, Jay R, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982: 307(27): 1676–81
- Castaldi PA. Hemostasis and kidney disease. In: Ratnoff OD, Forbes CD, eds. Disorders of hemostasis. New York: Grune & Stratton, 1984
- Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983: 308(1): 8–12
- Watson AJ, Keogh JA. Effect of 1-deamino-8-D-arginine vasopressin on the prolonged bleeding time in chronic renal failure. Nephron 1982: 32(1): 49–52
- Vigano G, Gaspari F, Locatelli M, et al. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 1988: 34(6): 853–8
- Janson PA, Jubelirer SJ, Weinstein MJ, et al. Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 1980: 303(23): 1318–22
- Livio M, Gotti E, Marchesi D, et al. Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 1982: 2(8306): 1013–5
- Abildgaard CF, Suzuki Z, Harrison J, et al. Serial studies in von Willebrand's disease: variability versus “variants.” Blood 1980: 56(4): 712–6
- Mannucci PM, Ruggeri ZM, Pareti FI, et al. 1-Deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's diseases. Lancet 1977: 1(8017): 869–72
- de la Fuente B, Kasper CK, Rickles FR, et al. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med 1985: 103(1): 6–14
- Ruggeri ZM, Pareti FI, Mannucci PM, et al. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980: 302(19): 1047–51
- Holmberg L, Nilsson IM, Borge L, et al. Platelet aggregation induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease. N Engl J Med 1983: 309(14): 816–21
- Walsh PN, Rizza CR, Matthews JM, et al. Epsilon-aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial. Br J Haematol 1971: 20(5): 463–75